Active

TRIMEPHAR

Switched

BE0807210244

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

17 year, 6 months

Registered office

Rue de la Champignotte(AIN) 13

4317 Faimes

België

Names & denominations

TRIMEPHAR

Official name

FR

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

20 October 2008

Contact

Not specified

Peppol

Active
0208:0807210244

Active since 10 Sept 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

47730 Main activity

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Champignotte(AIN) 13

4317 Faimes

2.175.726.133

Rue Albert Ier 119

5640 Mettet

Active since 1 January 2009

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of TRIMEPHAR?
The enterprise number of TRIMEPHAR is BE0807210244.
What is the address of TRIMEPHAR?
The registered office of TRIMEPHAR is located at Rue de la Champignotte(AIN) 13, 4317 Faimes.
When was TRIMEPHAR founded?
TRIMEPHAR was founded on 20 October 2008.
What is the main activity of TRIMEPHAR?
The main activity of TRIMEPHAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does TRIMEPHAR have a website?
No website is currently known for TRIMEPHAR.